Gemcitabine-Based Adjuvant Chemotherapy Improves Survival After Aggressive Surgery for Hilar Cholangiocarcinoma

被引：0
|
作者：
Yoshiaki Murakami
Kenichiro Uemura
Takeshi Sudo
Yasuo Hayashidani
Yasushi Hashimoto
Hiroaki Nakamura
Akira Nakashima
Taijiro Sueda
机构：
[1] Hiroshima University,Department of Surgery, Division of Clinical Medical Science, Graduate School of Biomedical Sciences
来源：
Journal of Gastrointestinal Surgery | 2009年 / 13卷
关键词：
Hilar cholangiocarcinoma; Prognostic factor; Postoperative adjuvant chemotherapy; Gemcitabine; S-1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1470 / 1479
页数：9
相关论文
共 50 条
  • [21] Adjuvant Chemotherapy and Radiation Therapy Improves Survival for Patients with Extrahepatic Cholangiocarcinoma
    Hoehn, R. S.
    Wima, K.
    Ertel, A.
    Meier, A. M.
    Ahmad, S.
    Sussman, J. J.
    Shah, S. A.
    Abbott, D. E.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S35 - S35
  • [22] Human Equilibrate Nucleoside Transporter 1 Expression Predicts Survival of Pancreatic Cancer Patients Trated With Gemcitabine-Based Adjuvant Chemotherapy After Resection
    Moriya, Toshiyuki
    Fuyama, Shigemi
    Kamio, Yukinori
    Ozawa, Koichiro
    Hasegawa, Shigeo
    Mizutani, Masaomi
    Higashi, Takayuki
    Yokoyama, Moriyoshi
    Usuba, Osamu
    GASTROENTEROLOGY, 2013, 144 (05) : S1080 - S1080
  • [23] What constitutes long term survival after surgery for hilar cholangiocarcinoma?
    Klempnauer, J
    Ridder, GJ
    Werner, M
    Weimann, A
    Pichlmayr, R
    CANCER, 1997, 79 (01) : 26 - 34
  • [24] Gemcitabine-based chemotherapy after FOLFIRINOX: a Portuguese retrospective multicenter analysis
    Neves, M.
    Alves, F.
    Barata, J.
    Graca, J.
    Matos, A.
    Eriz, I.
    Vitorinoo, M.
    Nogueira-Costa, G.
    Coelho, A.
    Pinto, M.
    Martins, A.
    ANNALS OF ONCOLOGY, 2019, 30
  • [25] Adjuvant chemotherapy improves overall survival after TME surgery in mucinous carcinoma of the rectum
    Chand, M.
    Rasheed, S.
    Bhangu, A.
    Stamp, G. W. H.
    Swift, R. I.
    Tekkis, P. P.
    Brown, G.
    EJSO, 2014, 40 (02): : 240 - 245
  • [26] Cholangiocarcinoma: Advocate an aggressive operative approach with adjuvant chemotherapy
    Kelley, ST
    Bloomston, M
    Serafini, F
    Carey, LC
    Karl, RC
    Zervos, E
    Goldin, S
    Rosemurgy, P
    Rosemurgy, AS
    AMERICAN SURGEON, 2004, 70 (09) : 743 - 748
  • [27] Improved outcomes after aggressive surgical resection of hilar cholangiocarcinoma: a critical analysis of recurrence and survival
    Saxena, Akshat
    Chua, Terence C.
    Chu, Francis C.
    Morris, David L.
    AMERICAN JOURNAL OF SURGERY, 2011, 202 (03): : 310 - 320
  • [28] Adjuvant Gemcitabine and Gemcitabine-based Chemoradiotherapy Versus Gemcitabine Alone After Pancreatic Cancer Resection The Indiana University Experience
    Khawaja, Muhammad R.
    Kleymau, Svetlana
    Yu, Zhangsheng
    Howard, Thomas
    Burns, Matthew
    Nakeeb, Attila
    Loehrer, Patrick J.
    Cardenes, Higinia R.
    Chiorean, Elena Gabriela
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2017, 40 (01): : 42 - 46
  • [29] Serum thrombospondin-1 serves as a novel biomarker and agonist of gemcitabine-based chemotherapy in intrahepatic cholangiocarcinoma
    Ding, Dong-yang
    Gan, Xiao-jie
    Zhang, Jia-ning
    Hou, Guo-jun
    Tao, Qi-fei
    Sun, Da-peng
    Li, Wen
    Yang, Yuan
    Ding, Wen-bin
    Yu, Jian
    Liu, Lei
    Yang, Fu
    Zhou, Wei-ping
    Yuan, Sheng-xian
    BRITISH JOURNAL OF CANCER, 2023, 128 (05) : 907 - 917
  • [30] GEMCITABINE-BASED COMBINATION CHEMOTHERAPY FOLLOWED BY RADIATION WITH CAPECITABINE AS ADJUVANT THERAPY FOR RESECTED PANCREAS CANCER
    Desai, Sameer
    Ben-Josef, Edgar
    Griffith, Kent A.
    Simeone, Diane
    Greenson, Joel K.
    Francis, Isaac R.
    Hampton, Janet
    Colletti, Lisa
    Chang, Alfred E.
    Lawrence, Theodore S.
    Zalupski, Mark M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (05): : 1450 - 1455
12345